Thomas Herz

Title: Thomas Herz: Innovator in Benzazole Compounds

Introduction

Thomas Herz is a notable inventor based in Stockdorf, Germany. He has made significant contributions to the field of chemistry, particularly in the development of benzazole analogues. With a total of 2 patents, his work focuses on compounds that have potential applications in medical treatments.

Latest Patents

Herz's latest patents include innovative compounds that are designed to serve as protein kinase inhibitors. The first patent, titled "Benzazole analogues and uses thereof," relates to compounds of general formulas (I), (Ia), and (II), along with their salts and physiologically functional derivatives. The substituents are attached to the 5- or 6-position of the benzazole. The second patent, also titled "Benzazole analogues and uses thereof," focuses on N-heteroaryl-benzazole-2,(5 or 6)-diamine derivatives and their compositions for treating conditions such as cancer.

Career Highlights

Thomas Herz is currently associated with 4SC AG, a company that specializes in the development of innovative therapies for cancer and autoimmune diseases. His work at 4SC AG has allowed him to explore the therapeutic potential of his patented compounds.

Collaborations

Throughout his career, Herz has collaborated with esteemed colleagues, including Rolf Krauss and Michael Kubbutat. These collaborations have further enriched his research and development efforts in the field of medicinal chemistry.

Conclusion

Thomas Herz is a prominent figure in the realm of benzazole compounds, with a focus on their medical applications. His contributions through patents and collaborations highlight his commitment to advancing scientific knowledge and therapeutic options.